microRNAs: a new class of endogenous antimicrobials for the treatment of infections in cystic fibrosis and beyond

被引:0
|
作者
Ye, Yunfei [1 ]
Sun, Yin He Richard [1 ]
Fitzpatrick, Fidelma [2 ]
Greene, Catherine M. . [1 ]
机构
[1] RSCI Univ Med & Hlth Sci, Dept Clin Microbiol, Lung Biol Grp, Dublin, Ireland
[2] RSCI Univ Med & Hlth Sci, Dept Clin Microbiol, Dublin, Ireland
关键词
antibiotic enhancing; antimicrobial resistance; cystic fibrosis; ESKAPE pathogens; microRNA; Pseudomonas aeruginosa; Staphylococcus aureus; therapeutics;
D O I
10.1080/17460913.2024.2357971
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:1041 / 1043
页数:3
相关论文
共 50 条
  • [21] Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis
    Epps, Quovadis J.
    Epps, Kevin L.
    Zobell, Jeffery T.
    Young, David C.
    PEDIATRIC PULMONOLOGY, 2020, 55 (12) : 3541 - 3572
  • [22] Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants
    Silva, Eduarda
    Monteiro, Rosana
    Grainha, Tania
    Alves, Diana
    Pereira, Maria Olivia
    Sousa, Ana Margarida
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [23] Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections
    Waters, Valerie J.
    Kidd, Timothy J.
    Canton, Rafael
    Ekkelenkamp, Miquel B.
    Johansen, Helle Krogh
    LiPuma, John J.
    Bell, Scott C.
    Elborn, J. Stuart
    Flume, Patrick A.
    VanDevanter, Donald R.
    Gilligan, Peter
    Bullington, Wendy
    Burgel, Pierre-Regis
    Byrnes, Catherine
    Drevinek, Pavel
    Holmes, Alison
    Kahl, Barbara
    Maples, Holly
    Martiniano, Stacey
    McColley, Susanna
    Morris, Andrew
    Muhlebach, Marianne
    Parkins, Michael
    Ratjen, Felix
    Roberts, Jason
    Saiman, Lisa
    Shah, Anand
    Smyth, Alan
    Somayaji, Ranjani
    Taccetti, Giovanni
    Tunney, Michael
    Winthrop, Kevin
    Zemanick, Edith
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (10) : 1812 - 1816
  • [24] Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections
    Warner, Nathaniel C.
    Bartelt, Luther A.
    Lachiewicz, Anne M.
    Tompkins, Kathleen M.
    Miller, Melissa B.
    Alby, Kevin
    Jones, Melissa B.
    Carr, Amy L.
    Alexander, Jose
    Gainey, Andrew B.
    Daniels, Robert
    Burch, Anna-Kathryn
    Brown, David E.
    Brownstein, Michael J.
    Cheema, Faiqa
    Linder, Kristin E.
    Shields, Ryan K.
    Longworth, Sarah
    van Duin, David
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E1754 - E1757
  • [25] Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic Fibrosis Airway Infections
    Cogen, Jonathan D.
    Nichols, David P.
    Goss, Christopher H.
    Somayaji, Ranjani
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2022, 11 : S32 - S39
  • [26] Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review
    Kirkby, Stephen
    Novak, Kimberly
    McCoy, Karen
    CORE EVIDENCE, 2011, 6 : 59 - 66
  • [27] In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections
    Mardirossian, Mario
    Pompilio, Arianna
    Crocetta, Valentina
    De Nicola, Serena
    Guida, Filomena
    Degasperi, Margherita
    Gennaro, Renato
    Di Bonaventura, Giovanni
    Scocchi, Marco
    AMINO ACIDS, 2016, 48 (09) : 2253 - 2260
  • [28] Synthesis and Characterization of Nanocomposite Microparticles (nCmP) for the Treatment of Cystic Fibrosis-Related Infections
    Zimeng Wang
    Samantha A. Meenach
    Pharmaceutical Research, 2016, 33 : 1862 - 1872
  • [29] The emerging potential of autophagy- based therapies in the treatment of cystic fibrosis lung infections
    Junkins, Robert D.
    McCormick, Craig
    Lin, Tong-Jun
    AUTOPHAGY, 2014, 10 (03) : 538 - 547
  • [30] Novel therapies for treatment of resistant and refractory nontuberculous mycobacterial infections in patients with cystic fibrosis
    Laudone, Thomas W.
    Garner, Lauren
    Kam, Charissa W.
    Esther, Charles R., Jr.
    McKinzie, Cameron J.
    PEDIATRIC PULMONOLOGY, 2021, 56 : S55 - S68